| Company Name: | Adcare Health Systems, Incorporated | | Ticker Symbol: | ADK | | | WWW Address: | www.adcarehealth.com | | CEO: | Gary L. Wade | | No. of Employees: | 575 | | Common Issue Type: | CS | | Business Description: | The Company is a developer, owner and manager of retirement communities, assisted living facilities, skilled nursing facilities and home health care services in the state of Ohio.
|
| | | Industry Information: | HEALTH SERVICES - Long-Term Care Facilities [more like this] |
|
| Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 2.6 |  0.059 | 2.46 | 3.25 | 2.58 | 2.60 | 2.58 | 500 |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 9.9 | 3.8 | 1.89 | -0.28 | 0.00 | 52.0 | 0.0 | 3.10 - 0.50 |
|
| KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 2.60 | $ | | PE Ratio - LTM | 52.0 | |
| Market Capitalisation | 9.8 | mil |
| Latest Shares Outstanding | 3.8 | mil |
| Earnings pS (EPS) | -0.28 | $ |
| Dividend pS (DPS) | 0.00 | ¢ |
| Dividend Yield | 0.0 | % |
| Dividend Payout Ratio | 0 | % |
| Revenue per Employee | 43,118 | $ |
| Effective Tax Rate | 0.0 | % |
| Float | 2.6 | mil |
| Float as % of Shares Outstanding | 68.3 | % |
| Foreign Sales | 0 | mil |
| Domestic Sales | 0 | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 31.90 | % |
| Research & Devlopment (R&D) as % of Revenue | 0.00 | % |
| Gross Profit Margin | 41.2 | % |
| EBITDA Margin | 9.3 | % |
| Pre-Tax Profit Margin | 1.2 | % |
| Assets Turnover | 1.0 | % |
| Return on Assets (ROA) | 0.6 | % |
| Return on Equity (ROE) | 3.0 | % |
| Return on Capital Invested (ROCI) | 0.7 | % |
| Current Ratio | 1.1 | |
| Leverage Ratio (Assets/Equity) | 5.3 | |
| Interest Cover | 1.3 | |
| Total Debt/Equity (Gearing Ratio) | 3.35 | |
| LT Debt/Total Capital | 76.0 | % |
| Working Capital pS | 0.10 | $ |
| Cash pS | 0.54 | $ |
| Book-Value pS | 1.36 | $ |
| Tangible Book-Value pS | 0.33 | $ |
| Cash Flow pS | 0.28 | $ |
| Free Cash Flow pS | 0.26 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 1.92 | |
| Price/Tangible Book Ratio | 7.80 | |
| Price/Cash Flow | 9.3 | |
| Price/Free Cash Flow | 10.0 | |
| P/E as % of Industry Group | 184.0 | % |
| P/E as % of Sector Segment | 0.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Type of Payment | - |
| Dividend Rate | 0.00 |
| Current Dividend Yield | 0.0 |
| 5-Y Average Dividend Yield | 0.0 |
| Payout Ratio | 0.0 |
| 5-Y Average Payout Ratio | 0.0 |
| |
| |
| |
| |
| |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | |
| |
| PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | 17.1 | 117 | 67 | 588 |
| 4 Weeks | 2.80 | 2.10 | 2.55 | 2.0 | 101 | 36 | 722 |
| 13 Weeks | 3.10 | 2.10 | 2.55 | 2.0 | 96 | 58 | 3,719 |
| 26 Weeks | 3.10 | 1.36 | 1.50 | 73.3 | 141 | 70 | 8,867 |
| 52 Weeks | 3.10 | 0.50 | 1.74 | 49.4 | 110 | 50 | 12,454 |
| YTD | 3.10 | 0.50 | - | 145.3 | 203 | 52 | 11,776 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 2.51 | 2.37 | 2.52 | 2.31 | 1.96 | 1.89 | 1.89 |
|
| |
| GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | 8.14 | 82.2 | 4.98 |
| Income | 0.00 | 0.0 | 0.00 |
| Dividend | 0.00 | 0.0 | 0.00 |
| Capital Spending | 0.00 | NA | 1.87 |
| R&D | 0.00 | NA | 0.00 |
| Normalized Inc. | 0.00 | NA | 0.00 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | 9.4 | 11.7 | 4.8 |
| Earnings % | 0.0 | 0.0 | 0.0 |
| EPS % | 0.0 | 0.0 | 0.0 |
| EPS $ | 0.33 | 0.23 | -0.23 |
|
| |
| SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | -2.01 |
| Current Ratio | 0.9 |
| Quick Ratio (Acid Test) | 0.8 |
| Liquidity Ratio (Cash) | 0.28 |
| Receivables Turnover | 10.6 |
| Average Collection Period | 34 |
| Working Capital/Equity | -11.9 |
| Working Capital pS | -0.14 |
| Cash-Flow pS | -0.05 |
| Free Cash-Flow pS | -0.01 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | 1.13 |
| Financial Leverage Ratio (Assets/Equity) | 5.9 |
| Debt Ratio | 83.1 |
| Total Debt/Equity (Gearing Ratio) | 3.92 |
| LT Debt/Equity | 3.76 |
| LT Debt/Capital Invested | 82.4 |
| LT Debt/Total Liabilities | 76.2 |
| Interest Cover | 0.3 |
| Interest/Capital Invested | 5.85 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 4.41 |
| Tobin's Q Ratio | 0.37 |
| Current P/E Ratio - LTM | 52.00 |
| Enterprise Value (EV)/EBITDA | 34.52 |
| Enterprise Value (EV)/Free Cash Flow | -878.18 |
| Dividend Yield | 0.0 |
| Price/Tangible Book Ratio - LTM | 7.80 |
| Price/Book Ratio - LTM | 1.92 |
| Price/Cash Flow Ratio | 9.3 |
| Price/Free Cash Flow Ratio - LTM | 10.0 |
| Price/Sales Ratio | 0.37 |
| P/E Ratio (1 month ago) - LTM | 54.0 |
| P/E Ratio (26 weeks ago) - LTM | 0.0 |
| P/E Ratio (52 weeks ago) - LTM | 0.0 |
| 5-Y High P/E Ratio | 0.0 |
| 5-Y Low P/E Ratio | 0.0 |
| 5-Y Average P/E Ratio | 0.0 |
| Current P/E Ratio as % of 5-Y Average P/E | 0 |
| P/E as % of Industry Group | 184.0 |
| P/E as % of Sector Segment | 0.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 14.2 |
| PER SHARE FIGURES |
| LT Debt pS | 4.49 |
| Current Liabilities pS | 1.21 |
| Tangible Book Value pS - LTM | 0.33 |
| Book Value pS - LTM | 1.36 |
| Capital Invested pS | 5.69 |
| Cash pS - LTM | 0.54 |
| Cash Flow pS - LTM | 0.28 |
| Free Cash Flow pS - LTM | 0.26 |
| Earnings pS (EPS) | -0.28 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | -0.15 |
| Free Cash Flow Margin 5YEAR AVG | -2.22 |
| Net Profit Margin | -4.3 |
| Net Profit Margin - 5YEAR AVRG. | -4.0 |
| Equity Productivity | 5.48 |
| Return on Equity (ROE) | 0.0 |
| Return on Equity (ROE) - 5YEAR AVRG. | 0.0 |
| Capital Invested Productivity | 1.15 |
| Return on Capital Invested (ROCI) | -5.0 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | -5.0 |
| Assets Productivity | 1.00 |
| Return on Assets (ROA) | -4.0 |
| Return on Assets (ROA) - 5YEAR AVRG. | -3.6 |
| Gross Profit Margin | 41.2 |
| Gross Profit Margin - 5YEAR AVRG. | 37.5 |
| EBITDA Margin - LTM | 9.3 |
| EBIT Margin - LTM | 5.6 |
| Pre-Tax Profit Margin | -3.7 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | -4.4 |
| Effective Tax Rate | -18.7 |
| Effective Tax Rate - 5YEAR AVRG. | 1.3 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 33 |
| Revenue per Employee | 43,118 |
| Net Income per Employee | -1,871 |
| Average Collection Period | 33 |
| Receivables Turnover | 10.6 |
| Day's Inventory Turnover Ratio | 0 |
| Inventory Turnover | 0.0 |
| Inventory/Sales | 0.0 |
| Accounts Payble/Sales | 6.99 |
| Assets/Revenue | 1.00 |
| Net Working Capital Turnover | -45.91 |
| Fixed Assets Turnover | 1.09 |
| Total Assets Turnover | 1.0 |
| Revenue per $ Cash | 19.58 |
| Revenue per $ Plant | 1.48 |
| Revenue per $ Common Equity | 5.48 |
| Revenue per $ Capital Invested | 1.15 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 33.3 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 31.8 |
| Research & Devlopment (R&D) as % of Revenue | 0.0 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 0.0 |
|
|  
|
| |
 |  |